Physician profile
Jack Hershman
NPI 1750333274
$559.43
in general payments reported to CMS, 2019-2025
14 companies · $26.54 in 2025
The $26.54 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $150 · 2020: $55.78 · 2021: $164 · 2022: $106 · 2023: $57.24 · 2025: $26.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $83.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $83.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $156.82 | 2021-2023 | Xtandi |
| Astrazeneca Pharmaceuticals Lp | $73.27 | 2019-2020 | |
| Janssen Biotech, INC. | $54.96 | 2019 | |
| Pfizer INC. | $47.09 | 2020-2023 | |
| Abbvie INC. | $28.24 | 2019 | |
| Calyxo, INC. | $26.54 | 2025 | Cvac Aspiration System |
| Procept Biorobotics Corporation | $26.41 | 2021 | |
| Teleflex LLC | $25.09 | 2023 | Urolift |
| Bayer Healthcare Pharmaceuticals INC. | $24.96 | 2022 | |
| Photocure INC | $24.45 | 2022 | |
| 180 Medical, INC. | $24.37 | 2022 | |
| Dentsply Ih INC. | $16.00 | 2022 | |
| Coloplast Corp | $15.71 | 2019 | |
| Endo Pharmaceuticals INC. | $15.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Hershman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.